Bergstrom Donald A's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Sep 9, 2026
- Accession no.
- 0001193125-26-386473
- Filed
- Sep 9, 2026, 4:17 PM ET
- Trade date
- Sep 8, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $161.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bergstrom Donald ACIK 0001709772 | Officer (President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | SSaleDisposed | −8,530 | $18.97 | −$161,814.1 | 399,130 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.